TNFSF4: A Protein Potential for Cancer and Inflammatory Diseases

Target Name: TNFSF4

NCBI ID: G7292

TNFSF4

TNFSF4: A Protein Potential for Cancer and Inflammatory Diseases

TNFSF4, also known as Tumor necrosis factor ligand superfamily member 4 isoform X3, is a protein that is expressed in a variety of tissues throughout the body, including the liver, spleen, and blood cells. It is a member of the TNFSF4 gene family, which is characterized by the presence of a unique transmembrane domain that is involved in the formation of the superfamily.

TNFSF4 isoform X3 is a unique isoform of the TNFSF4 gene that has been shown to play a unique role in the regulation of cellular processes throughout the body. It is expressed in a variety of tissues and has been shown to be involved in the development and progression of a number of diseases, including cancer.

One of the key functions of TNFSF4 is its ability to stimulate the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. These cytokines play a critical role in the regulation of immune and inflammatory responses throughout the body, and are often involved in the development and progression of a number of diseases, including cancer.

In addition to its role in the production of pro-inflammatory cytokines, TNFSF4 is also involved in the regulation of cellular signaling pathways that are critical for the development and maintenance of tissues and organs. This includes the regulation of cell adhesion, the formation of blood vessels, and the regulation of cell signaling pathways that are involved in the development and maintenance of tissues and organs.

TNFSF4 is also involved in the regulation of cellular processes that are critical for the development and maintenance of the immune system. This includes the regulation of T cell development and the regulation of the immune response to infection.

Given its involvement in a wide range of cellular processes throughout the body, it is likely that TNFSF4 could be a drug target or biomarker for a variety of diseases. For example, it is possible that TNFSF4 could be a potential target for cancer therapies that are designed to inhibit the production of pro-inflammatory cytokines and/or to regulate the immune response. In addition, TNFSF4 may also be a potential biomarker for a variety of diseases, including cancer, as it is expressed in a variety of tissues and can be easily isolated and measured.

Overall, TNFSF4 is a unique and fascinating protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic target.

Protein Name: TNF Superfamily Member 4

Functions: Cytokine that binds to TNFRSF4. Co-stimulates T-cell proliferation and cytokine production

The "TNFSF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TNFSF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets